clinic
manifest
human
coronaviru
hcov
infect
rang
mild
ill
upper
respiratori
tract
acut
respiratori
distress
syndrom
high
mortal
rate
highli
virul
speci
hcov
respons
outbreak
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
rate
rang
contrast
hcov
speci
much
preval
much
less
sever
common
caus
ill
ili
five
previou
studi
describ
clinic
characterist
hcov
infect
among
two
studi
signific
proport
studi
popul
underli
medic
herein
describ
among
cohort
otherwis
healthi
adolesc
adult
ill
ili
preval
sever
symptom
associ
hcov
infect
acut
respiratori
infect
consortium
aric
multisit
multidisciplinari
clinic
research
network
studi
ili
us
depart
defens
dod
healthcar
facil
establish
aric
natur
histori
studi
observ
longitudin
cohort
studi
etiolog
epidemiolog
clinic
characterist
ili
among
otherwis
healthi
dod
member
patient
year
age
present
care
hour
onset
ili
symptom
recruit
studi
particip
ili
defin
temperatur
sore
throat
one
follow
respiratori
symptom
cough
sputum
product
short
breath
chest
pain
inpati
outpati
subject
elig
particip
patient
underli
medic
condit
eg
diabet
chronic
obstruct
pulmonari
diseas
sever
asthma
women
complic
pregnanc
patient
poorli
control
psychiatr
disord
exclud
nasopharyng
np
swab
copan
diagnost
corona
ca
collect
baselin
ie
enrol
detect
respiratori
pathogen
swab
place
immedi
viral
transport
media
frozen
ship
dri
ice
naval
health
research
center
san
diego
ca
specimen
test
influenza
cdc
human
influenza
viru
revers
transcript
polymeras
chain
reaction
aliquot
test
diatherix
laboratori
llc
huntsvil
al
multiplex
assay
detect
viral
bacteri
respiratori
pathogen
viral
target
includ
influenza
influenza
b
respiratori
syncyti
viru
rsv
type
b
rhinovirusenteroviru
parainfluenza
viru
type
human
metapneumoviru
hmpv
adenoviru
type
b
e
coronaviru
speci
inform
patient
demograph
presencesever
symptom
time
enrol
collect
interview
particip
instruct
use
daili
diari
record
presencesever
symptom
day
follow
initi
symptom
onset
symptom
sever
rate
ordin
scale
none
sever
symptom
sever
score
quantifi
use
follow
five
measur
individu
symptom
score
symptom
ii
upper
respiratori
symptom
score
calcul
sum
sever
score
earach
runni
nose
sore
throat
sneez
iii
lower
respiratori
symptom
score
calcul
sum
sever
score
cough
difficulti
breath
hoars
chest
discomfort
iv
gastrointestin
symptom
score
calcul
sum
sever
score
diarrhea
vomit
anorexia
nausea
abdomin
pain
v
composit
system
symptom
score
calcul
sum
sever
score
chill
muscl
ach
headach
fatigu
differ
patient
demograph
studi
site
ili
risk
factor
hcov
speci
compar
use
descript
statist
eg
fisher
exact
test
composit
symptom
score
confid
interv
ci
calcul
evalu
speci
differ
clinic
characterist
statist
comparison
perform
use
test
exploratori
analysi
differ
symptom
sever
correct
multipl
comparison
made
analys
perform
use
spss
version
ibm
corpor
armonk
ny
studi
approv
infecti
diseas
institut
review
board
uniform
servic
univers
health
scienc
total
particip
enrol
aric
nh
baselin
nasopharyng
specimen
evalu
posit
hcov
case
occur
septemb
june
highest
number
case
occur
februari
fourteen
case
posit
anoth
viral
respiratori
pathogen
includ
human
rhinoviru
adenoviru
influenza
influenza
b
fifteen
case
year
age
two
group
subject
exclud
analysi
symptom
sever
remain
case
mean
rang
age
year
white
femal
activ
duti
militari
member
tabl
one
subject
hospit
durat
day
distribut
hcov
speci
follow
among
patient
year
age
common
speci
wherea
common
speci
among
adult
differ
speci
respect
sex
geograph
locat
raceethn
smoke
statu
season
enrol
militari
statu
case
tabl
variabl
lead
caus
ill
common
strain
identifi
account
infect
respect
common
strain
identifi
account
infect
respect
median
daili
composit
symptom
sever
score
first
day
ill
stratifi
hcov
speci
present
figur
hcov
speci
symptom
categori
score
peak
studi
day
subject
report
persist
symptom
day
ill
differ
hcov
speci
respect
sever
upper
respiratori
lower
respiratori
system
symptom
time
studi
day
median
composit
sever
score
gastrointestin
symptom
trend
higher
among
infect
compar
speci
although
differ
statist
signific
p
otherwis
preval
sever
symptom
differ
speci
find
studi
conduct
period
five
geograph
dispers
site
usa
demonstr
human
coronaviru
hcov
import
caus
ill
ili
among
otherwis
healthi
adolesc
adult
twelv
percent
case
ili
popul
attribut
hcov
infect
proport
adult
popul
rang
addit
found
common
speci
among
adult
report
common
strain
altern
season
reflect
variabl
hcov
strain
circul
report
multiyear
reason
season
variat
unknown
may
reflect
differ
composit
studi
popul
respect
age
group
geograph
locat
addit
epidemiolog
factor
small
sampl
size
preclud
analysi
factor
associ
hcov
season
variat
nearli
categori
timepoint
longitudin
assess
symptom
presencesever
reveal
signific
differ
four
hcov
speci
one
except
report
sever
gastrointestin
symptom
higher
among
individu
infect
although
differ
reach
statist
signific
case
studi
adult
infect
report
presenc
upper
lower
gastrointestin
mechan
particular
speci
elicit
symptom
known
strength
studi
hcov
otherwis
healthi
adolesc
adult
includ
multisit
multiyear
design
use
multiplex
diagnost
panel
prospect
collect
symptom
data
use
symptom
sever
scale
similar
employ
one
import
limit
studi
select
recruit
individu
present
healthcar
facil
care
ili
therefor
case
repres
hcov
infect
commun
individu
mild
ill
due
hcov
opt
seek
medic
care
manag
ili
summari
shown
hcov
signific
caus
ili
among
otherwis
healthi
adolesc
adult
present
medic
evalu
although
differ
speci
distribut
age
group
detect
differ
speci
respect
clinic
spectrum
diseas
content
public
sole
respons
author
necessarili
reflect
view
opinion
polici
uniform
servic
univers
health
scienc
usuh
depart
defens
dod
depart
armi
navi
air
forc
henri
jackson
foundat
advanc
militari
medicin
mention
trade
name
commerci
product
organ
impli
endors
us
govern
investig
adher
polici
protect
human
subject
prescrib
